| 000 | 00786nam a22002177a 4500 | ||
|---|---|---|---|
| 003 | ES-MaBCA | ||
| 005 | 20141222094644.0 | ||
| 008 | 120810t xxu||||| |||| 00| 0 eng d | ||
| 020 | _a978-92-9168-601-8 | ||
| 024 |
_2doi _a10.2810/86512 |
||
| 040 | _cES-MaBCA | ||
| 245 |
_a4-Methylamphetamine (4-MA) _h[Recurso electrónico]PDF |
||
| 260 |
_c2014 _aLuxembourg _bPublications Office of the European Union |
||
| 300 |
_a59 p. _fRecurso online |
||
| 490 |
_aRisk Assessments _x1725-4493 _v10 |
||
| 650 |
_93911 _aDrogas _xPrevención |
||
| 651 |
_91574 _aPaíses de la Unión Europea |
||
| 710 |
_92663 _aObservatorio Europeo de Drogas y Toxicomanías |
||
| 856 | 4 | _uhttp://www.emcdda.europa.eu/attachements.cfm/att_222680_EN_TDAK13001ENN.pdf | |
| 942 |
_2udc _cINF _kBoletín UE _mEnero 2014 |
||
| 999 |
_c4933 _d4936 |
||